Take an inside look at how the home care industry fared during the early stages of PDGM with an in-depth analysis presented by BlackTree Managing Principal Nick Seabrook and SHP Vice President of Product Strategy Chris Attaya. Using SHP’s robust, real-time provider data, we’ll examine clinical, operational and financial indicators and measure the impact of COVID-19 on PDGM performance. We’ll also discuss how agencies should be completing their own internal analysis of actual agency performance under PDGM compared to projections.
Mr. Seabrook’s operations expertise has helped agencies improve profitability and reimbursement. Specifically, he has provided extensive revenue cycle consulting throughout his career, focused on improving daily operations of many providers. He has worked with agencies of all sizes throughout the country. In addition to traditional revenue cycle consulting, Mr. Seabrook has served as an interim director of patient accounts, interim finance manager and interim Chief Financial Officer.
Vice President, Product Strategy
Chris Attaya brings more than 28 years of experience in the Home Health and Hospice industry, achieved through a series of executive and consulting positions. Chris joined SHP in 2014, and is responsible for product development and client relationships to help clients achieve increased operational and financial performance through the use of SHP’s industry leading analytics platform and benchmark data. Prior to SHP, Chris was the CFO at the Visiting Nurse Association of Boston and had worked at Partners Health Care at Home as CFO and CEO. He received a BA in Public Health from Tufts University and an MBA from the Graduate School of Management at Boston University concentrating in Health Care Finance.